Cargando…

Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer

PURPOSE: To test the psychometric properties and applicability of the European Organization for Research and Treatment of Cancer In-patient Satisfaction with Care Questionnaire 32 (EORTC IN-PATSAT32) for Chinese patients with gastrointestinal cancer. PATIENTS AND METHODS: A total of 106 inpatients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jishui, Xie, Shumin, Liu, Jiahao, Sun, Weilin, Guo, Hui, Hu, Yingbin, Gao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174132/
https://www.ncbi.nlm.nih.gov/pubmed/25258522
http://dx.doi.org/10.2147/PPA.S67111
_version_ 1782336308821098496
author Zhang, Jishui
Xie, Shumin
Liu, Jiahao
Sun, Weilin
Guo, Hui
Hu, Yingbin
Gao, Xin
author_facet Zhang, Jishui
Xie, Shumin
Liu, Jiahao
Sun, Weilin
Guo, Hui
Hu, Yingbin
Gao, Xin
author_sort Zhang, Jishui
collection PubMed
description PURPOSE: To test the psychometric properties and applicability of the European Organization for Research and Treatment of Cancer In-patient Satisfaction with Care Questionnaire 32 (EORTC IN-PATSAT32) for Chinese patients with gastrointestinal cancer. PATIENTS AND METHODS: A total of 106 inpatients with gastrointestinal cancer at Cangzhou Center Hospital were enrolled in this study. All were treated at Cangzhou Center Hospital from July 2013–March 2014. All participants self-administered the EORTC IN-PATSAT32 and EORTC Quality of Life Questionnaire – Core 30 (EORTC QLQ-C30). RESULTS: The Cronbach’s α coefficients were >0.70 for all scales of the EORTC IN-PATSAT32. Multitrait scaling analysis showed that all-item scale correlation coefficients met the standard of convergent validity, while only 50.0% met the standard of discriminant validity. A weak correlation was found between the scales and single items of the EORTC IN-PATSAT32 and EORTC QLQ-C30. CONCLUSION: The EORTC IN-PATSAT32 appears to be a reliable, valid, and acceptable instrument for measuring patient satisfaction among Chinese patients with gastrointestinal cancer.
format Online
Article
Text
id pubmed-4174132
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-41741322014-09-25 Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer Zhang, Jishui Xie, Shumin Liu, Jiahao Sun, Weilin Guo, Hui Hu, Yingbin Gao, Xin Patient Prefer Adherence Original Research PURPOSE: To test the psychometric properties and applicability of the European Organization for Research and Treatment of Cancer In-patient Satisfaction with Care Questionnaire 32 (EORTC IN-PATSAT32) for Chinese patients with gastrointestinal cancer. PATIENTS AND METHODS: A total of 106 inpatients with gastrointestinal cancer at Cangzhou Center Hospital were enrolled in this study. All were treated at Cangzhou Center Hospital from July 2013–March 2014. All participants self-administered the EORTC IN-PATSAT32 and EORTC Quality of Life Questionnaire – Core 30 (EORTC QLQ-C30). RESULTS: The Cronbach’s α coefficients were >0.70 for all scales of the EORTC IN-PATSAT32. Multitrait scaling analysis showed that all-item scale correlation coefficients met the standard of convergent validity, while only 50.0% met the standard of discriminant validity. A weak correlation was found between the scales and single items of the EORTC IN-PATSAT32 and EORTC QLQ-C30. CONCLUSION: The EORTC IN-PATSAT32 appears to be a reliable, valid, and acceptable instrument for measuring patient satisfaction among Chinese patients with gastrointestinal cancer. Dove Medical Press 2014-09-18 /pmc/articles/PMC4174132/ /pubmed/25258522 http://dx.doi.org/10.2147/PPA.S67111 Text en © 2014 Zhang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zhang, Jishui
Xie, Shumin
Liu, Jiahao
Sun, Weilin
Guo, Hui
Hu, Yingbin
Gao, Xin
Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer
title Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer
title_full Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer
title_fullStr Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer
title_full_unstemmed Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer
title_short Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer
title_sort validation of eortc in-patsat32 for chinese patients with gastrointestinal cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174132/
https://www.ncbi.nlm.nih.gov/pubmed/25258522
http://dx.doi.org/10.2147/PPA.S67111
work_keys_str_mv AT zhangjishui validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer
AT xieshumin validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer
AT liujiahao validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer
AT sunweilin validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer
AT guohui validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer
AT huyingbin validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer
AT gaoxin validationofeortcinpatsat32forchinesepatientswithgastrointestinalcancer